. home.aspx

NEWS

home.aspx
   


Sirnaomics closes second portion of $47M Series C round for RNA interference drugs

April 29, 2019 / ALARIC DEARMENT
SHARESHARESHARE

The firm announced that it closed a $22 million Series C2 round, following a $25 million Series C1 round that it had closed last June, led by Asian investors.